KALA BIO
KALA
64 hedge funds and large institutions have $84.4M invested in KALA BIO in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 7 closing their positions.
169% more call options, than puts
Call options by funds: $395K | Put options by funds: $147K
62% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 13
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2% more funds holding
Funds holding: 63 → 64 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3.65% less ownership
Funds ownership: 68.89% → 65.24% (-3.7%)
43% less capital invested
Capital invested by funds: $149M → $84.4M (-$64.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.51M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$876K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$828K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$645K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$511K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$6.65M |
| 2 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$3.23M |
| 3 |
FI
Fosun International
Hong Kong,
China
|
-$1.45M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$986K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$913K |
KALA Hedge Fund Activity: Q3 2019 in Review
64 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q3 2019, worth a combined $84.4M — down 43% from $149M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new KALA positions and 7 closed out — a net gain of 1 holder — while 21 added to existing stakes and 13 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $1.51M. The largest seller was Vivo Capital, exiting entirely with an estimated $6.65M sold.
- 64 institutional investors held KALA BIO (KALA) as of Q3 2019, up from 63 in Q2 2019.
- Funds reported $84.4M of KALA BIO stock for Q3 2019, down 43% quarter-over-quarter.
- 8 funds opened new KALA BIO positions in Q3 2019 and 7 closed out, a net change of +1 holder.
- The largest KALA BIO buyer in Q3 2019 was Point72 Asset Management, an estimated $1.51M added.
- The largest KALA BIO seller in Q3 2019 was Vivo Capital, an estimated $6.65M sold.
Based on aggregated 13F filings for Q3 2019.